Clinical Trials Logo

Retained Blood Syndrome clinical trials

View clinical trials related to Retained Blood Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT05308589 Terminated - Clinical trials for Cardiac Surgical Procedures

CPPF After General Cardiac Surgery

FLUID
Start date: November 2, 2021
Phase: N/A
Study type: Interventional

In two randomized clinical trials the investigators have demonstrated that continuous postoperative pericardial flushing (CPPF) therapy can reduce postoperative blood loss and bleeding-related complications after cardiac surgery and that CPPF therapy is safe and feasible in an experimental setting. The Haermonics investigational device is a novel medical device that enables CPPF therapy to be used in daily clinical setting. The aim of this study is three-fold. First, to evaluate the safety and functionality of the Haermonics investigational device. Secondly, to investigate the effect of CPPF therapy on bleeding related complications in the adulty cardiac surgery population. Thirdly, to explore the effect of CPPF therapy on intraluminal chest tube clogging.

NCT ID: NCT02682849 Completed - Clinical trials for Retained Blood Syndrome

Active Clearance Technology (ACT) Registry

Start date: May 10, 2016
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate the effectiveness of the PleuraFlow® Active Clearance Technologyâ„¢ (ACT) System in the management of blood evacuation after cardiac surgery.